Interpretation of trial-based economic evaluations of musculoskeletal physical therapy interventions

被引:20
|
作者
Miyamoto, Gisela Cristiane [1 ,2 ]
Ben, Angela Jornada [2 ]
Bosmans, Judith E. [2 ]
van Tulder, Maurits W. [3 ]
Lin, Chung-Wei Christine [4 ]
Nunes Cabral, Cristina Maria [1 ]
van Dongen, Johanna Maria [2 ]
机构
[1] Univ Cidade Sao Paulo, Masters & Doctoral Program Phys Therapy, Sao Paulo, Brazil
[2] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, Amsterdam Publ Hlth, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, Amsterdam Movement Sci, Amsterdam, Netherlands
[4] Univ Sydney, Sch Publ Hlth, Inst Musculoskeletal Hlth Sydney, Sydney, NSW, Australia
基金
英国医学研究理事会; 巴西圣保罗研究基金会;
关键词
Netherlands; Health technology; Rehabilitation; LOW-BACK-PAIN; COST-EFFECTIVENESS ANALYSIS; ALONGSIDE CLINICAL-TRIALS; MIDDLE-INCOME COUNTRIES; RANDOMIZED-TRIALS; WORK LIMITATIONS; CONFIDENCE-INTERVALS; PRODUCTIVITY COSTS; DECISION-MAKING; NECK PAIN;
D O I
10.1016/j.bjpt.2021.06.011
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: As resources for healthcare are scarce, decision-makers increasingly rely on economic evaluations when making reimbursement decisions about new health technologies, such as drugs, procedures, devices, and equipment. Economic evaluations compare the costs and effects of two or more interventions. Musculoskeletal disorders have a high prevalence and result in high levels of disability and high costs worldwide. Because physical therapy interventions are usually the first line of treatment for musculoskeletal disorders, economic evaluations of such interventions are becoming increasingly important for stakeholders in the field of physical therapy, including physical therapists, decision-makers, and reseachers. However, economic evaluations are relatively difficult to interpret for the majority of stakeholders. Objective: To support physical therapists, decision-makers, and researchers in the field of physical therapy interpreting trial-based economic evaluations and translating the results of such studies to clinical practice. Methods: The design, analysis, and interpretation of economic evaluations performed alongside randomized controlled trials are discussed. To further illustrate and explain these concepts, we use a case study assessing the cost-effectiveness of exercise therapy compared to standard advice in patients with musculoskeletal disorders. Conclusions: Economic evaluations are increasingly being used in healthcare decision-making. Therefore, it is of utmost importance that their design, conduct, and analysis are state-of-theart and that their interpretation is adequate. This masterclass will help physical therapists, decision-makers, and researchers in the field of physical therapy to critically appraise the quality and
引用
收藏
页码:514 / 529
页数:16
相关论文
共 50 条
  • [1] Conducting Trial-Based Economic Evaluations Using R: A Tutorial
    Ben, Angela Jornada
    van Dongen, Johanna M.
    El Alili, Mohamed
    Esser, Jonas L.
    Broulikova, Hana Marie
    Bosmans, Judith E.
    PHARMACOECONOMICS, 2023, 41 (11) : 1403 - 1413
  • [2] Trial-Based Economic Evaluations in Occupational Health Principles, Methods, and Recommendations
    van Dongen, Johanna M.
    van Wier, Marieke F.
    Tompa, Emile
    Bongers, Paulien M.
    van der Beek, Allard J.
    van Tulder, Maurits W.
    Bosmans, Judith E.
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2014, 56 (06) : 563 - 572
  • [3] Taking the Analysis of Trial-Based Economic Evaluations to the Next Level: The Importance of Accounting for Clustering
    El Alili, Mohamed
    van Dongen, Johanna M.
    Goldfeld, Keith S.
    Heymans, Martijn W.
    van Tulder, Maurits W.
    Bosmans, Judith E.
    PHARMACOECONOMICS, 2020, 38 (11) : 1247 - 1261
  • [4] Cost-Effectiveness of Treatments for Musculoskeletal Conditions Offered by Physiotherapists: A Systematic Review of Trial-Based Evaluations
    Baumbach, Linda
    Feddern, Wiebke
    Kretzler, Benedikt
    Hajek, Andre
    Koenig, Hans-Helmut
    SPORTS MEDICINE-OPEN, 2024, 10 (01)
  • [5] Risk of bias in trial-based economic evaluations: Identification of sources and bias-reducing strategies
    Evers, Silvia M. A. A.
    Hiligsmann, Mickael
    Adarkwah, Charles Christian
    PSYCHOLOGY & HEALTH, 2015, 30 (01) : 52 - 71
  • [6] What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations?
    van Dongen, Johanna M.
    El Alili, Mohamed
    Varga, Anita N.
    Morel, Alejandra E. Guevara
    Ben, Angela Jornada
    Khorrami, Mojdeh
    van Tulder, Maurits W.
    Bosmans, Judith E.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (01) : 27 - 37
  • [7] Linear mixed models to handle missing at random data in trial-based economic evaluations
    Gabrio, Andrea
    Plumpton, Catrin
    Banerjee, Sube
    Leurent, Baptiste
    HEALTH ECONOMICS, 2022, 31 (06) : 1276 - 1287
  • [8] The statistical approach in trial-based economic evaluations matters: get your statistics together!
    Mutubuki, Elizabeth N.
    El Alili, Mohamed
    Bosmans, Judith E.
    Oosterhuis, Teddy
    J. Snoek, Frank
    Ostelo, Raymond W. J. G.
    van Tulder, Maurits W.
    van Dongen, Johanna M.
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [9] Joint Longitudinal Models for Dealing With Missing at Random Data in Trial-Based Economic Evaluations
    Gabrio, Andrea
    Hunter, Rachael
    Mason, Alexina J.
    Baio, Gianluca
    VALUE IN HEALTH, 2021, 24 (05) : 699 - 706
  • [10] Explanatory versus pragmatic trial-based economic evaluations: application to alternative therapies for burns
    Carayanni, Vilelmine
    Tsati, Evangelia
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (01) : 37 - 48